SYT1 and Cognitive impairment: In addition, in sample set I the synaptotagmin-1 level was significantly higher in patients with mild cognitive impairment due to Alzheimer’s disease compared with patients with dementia due to Alzheimer’s disease (P ≤ 0.05).